Keywords: novartis, visudyne, use, extended, eu, ophthalmics, been

Novartis's Visudyne use extended in EU

Article | 26 March 2001

Novartis Ophthalmics has been granted approval in the European Union tomarket Visudyne (verteporfin) for a new indication, the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in